Title: Traveler’s Diarrhea Treatment Market by Drug Class, Pathogen and Forecast to 2027
1Travelers Diarrhea Treatment Market
Travelers Diarrhea Treatment Market Segmentation
by Drug Class Oral Rehydration Therapy (ORS),
Antidiarrheal Agents, Antibiotics Azithromycin,
Ciprofloxacin, Quinolones, and Rifaximi,
Vaccines/Prophylactics, and Others Pathogen
Bacteria E. Coli, Salmonella Spp, and Others,
Viruses, and Protozoa Age Group Adults and
Children and Distribution Channel Retail
Pharmacies, Hospital Pharmacies, and Online
Pharmacies, Forecast, 2019 - 2027
2019 Transparency Market Research, All Rights
Reserved
2Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global Travelers Diarrhea Treatment Market
Chapter 4 Market Overview
Chapter 5 Global Travelers Diarrhea Treatment Market Analysis and Forecast, by Drug Class
Chapter 6 Global Travelers Diarrhea Treatment Market Analysis and Forecast, by Pathogen
Chapter 7 Global Travelers Diarrhea Treatment Market Analysis and Forecast, by Age
Chapter 8 Global Travelers Diarrhea Treatment Market Analysis and Forecast, by Distribution Channel
Chapter 9 Global Travelers Diarrhea Treatment Market Analysis and Forecast, by Region
Chapter 10 North America Travelers Diarrhea Treatment Market Analysis and Forecast
Chapter 11 Europe Travelers Diarrhea Treatment Market Analysis and Forecast
Chapter 12 Asia Pacific Travelers Diarrhea Treatment Market Analysis and Forecast
Chapter 13 Latin America Travelers Diarrhea Treatment Market Analysis and Forecast
Chapter 14 Middle East Africa Travelers Diarrhea Treatment Market Analysis and Forecast
Chapter 15 Competition Landscape
2019 Transparency Market Research, All Rights
Reserved
3 Travelers Diarrhea Treatment Market - Snapshot
- Travelers diarrhea is a stomach and intestinal
infection caused due to a bacterial, viral or
protozoal infection. It is commonly caused due to
a bacterial infection. - Antidiarrheal agents are the first line treatment
for travelers diarrhea and are used for mild,
moderate, and severe diarrhea caused while
travelling. - The risk of travelers diarrhea is low in
developed countries such as the U.S., Australia,
New Zealand, Japan, and those in Europe.
2019 Transparency Market Research, All Rights
Reserved
4(No Transcript)
5Report Highlights
- The Global travelers diarrhea treatment market
is expected to reach a value of US 1.3 Bn by
2027. - The travelers diarrhea treatment market is
expanding at a rapid pace, as awareness among
travelers related to ill effects of travelers
diarrhea is increasing. - Antibiotic prophylaxis is used to prevent
travelers diarrhea, which is primarily caused by
bacterial etiologies. - Industry players are focused on RD to introduce
new therapeutic products for the treatment of
travelers diarrhea.
Request For Sample
2019 Transparency Market Research, All Rights
Reserved
6(No Transcript)
7Continue..
- Key players are expanding their footprint to
strengthen their position in the global
travelers diarrhea treatment market. - Prominent players operating in the global
travelers diarrhea treatment market are Johnson
Johnson (Johnson Johnson Consumer Inc.),
Bausch Health Companies Inc. - The goal of pre-travel consultation is to improve
the understanding of travelers about
travel-related health hazards and diseases.
Request For Brochure
2019 Transparency Market Research, All Rights
Reserved
8Contact
To know more about us, please visit our website
www.transparencymarketresearch.com For sales
queries or new topics email us on
sales_at_transparencymarketresearch.com
Thank You
2019 Transparency Market Research, All Rights
Reserved